283 results on '"BUDERATH, Paul"'
Search Results
2. Peritoneal mesometrial resection with lymphadenectomy following prior hysterectomy in intermediate/high-risk endometrial cancer: feasibility and safety
3. Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial
4. Sentinel Lymph node detection in endometrial cancer - Anatomical and scientific facts
5. Uterine Nische: geburtshilfliche und gynäkologische Folgen: Was sollen wir über diese zunehmend häufige Diagnose wissen und wie sollten wir Patientinnen beraten?
6. Molecular Characterization of Single Circulating Tumor Cells in Breast and Ovarian Cancer
7. Hysterectomy in benign conditions: a 20-year single-center retrospective on the development of surgical techniques
8. Hysterektomie im Wandel der Zeit: Retrospektive Analyse der operativen Techniken in den letzten 20 Jahren an der Universitätsfrauenklinik Essen
9. Single-center study for robotic-assisted laparoscopic sacropexies: a one-fits-all strategy for pelvic organ prolapse?
10. Treatment strategies in patients with gynecological sarcoma: Results of the prospective intergroup real-world registry for gynecological sarcoma in Germany (REGSA-NOGGO RU1)
11. Molecular Characterization of Single Circulating Tumor Cells in Breast and Ovarian Cancer
12. Totale mesometriale Resektion (TMMR) + therapeutische Lymphonodektomie (tLNE) beim Zervixkarzinom FIGO IB – IIAIIA: Erste Ergebnisse der multizentrischen TMMR-Registerstudie
13. The effect of fertility-sparing surgery on sexuality and global quality of life in women with malignant ovarian germ cell and sex cord stromal tumors: an analysis of the CORSETT database of the AGO study group
14. Krebsfeldchirurgie des Endometriumkarzinoms: Erste Ergebnisse zur lokoregionären Kontrolle durch PMMR und „targeted compartmental lymphadenectomy“
15. A randomized, double-blind, placebo-controlled phase 1b/2 study of ralimetinib, a p38 MAPK inhibitor, plus gemcitabine and carboplatin versus gemcitabine and carboplatin for women with recurrent platinum-sensitive ovarian cancer
16. Sentineltechnik mit ICG in der Gynäkologie: Literaturübersicht und eigene Erfahrungen
17. Tumor cell cytoplasmic metallothionein expression associates with differential tumor immunogenicity and prognostic outcome in high-grade serous ovarian carcinoma
18. Supplementary Figure S1 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
19. Supplementary Table S2 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
20. Data from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
21. Supplementary Appendix S1 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
22. ESR1 methylation in primary tumors and paired circulating tumor DNA of patients with high-grade serous ovarian cancer
23. Kompartmentbasierte Chirurgie und Sentinel-Konzept beim Endometriumkarzinom: der Essener Weg: Vorschlag für eine rationale, risikoadaptierte chirurgische Therapie
24. Prognostic significance of PD-1 and PD-L1 positive tumor-infiltrating immune cells in ovarian carcinoma
25. HLA-G 3′ untranslated region variants +3187G/G, +3196G/G and +3035T define diametrical clinical status and disease outcome in epithelial ovarian cancer
26. Treatment and survival of patients with malignant ovarian sex cord‐stromal cell tumours: An analysis of the Arbeitsgemeinschaft für Gynäkologische Onkologie (AGO) study group CORSETT database
27. Ovarialkarzinom: Perioperatives Management
28. Embryologically based radical hysterectomy as peritoneal mesometrial resection (PMMR) with pelvic and para-aortic lymphadenectomy for loco-regional tumor control in endometrial cancer: first evidence for efficacy
29. ICG-gestützte Navigation bei der Chirurgie uteriner Malignome
30. Hysterectomy in benign conditions: a 20-year single-center retrospective on the development of surgical techniques
31. 2022-RA-798-ESGO Diagnosis of first relapse and its impact on quality of life in patients with advanced ovarian cancer (AGO-OVAR 19/II)
32. COVID-19 – Auswirkungen der Pandemie auf Behandlungsgeschehen und Erlössituation
33. Detection of ESR1 Mutations in Primary Tumors and Plasma Cell-Free DNA in High-Grade Serous Ovarian Carcinoma Patients
34. Diagnosis of first relapse and its impact on quality of life in patients with advanced ovarian cancer (AGO-OVAR 19/II).
35. Epidemiological and demographic characteristics of gynecological sarcoma: Results of the prospective intergroup registry for gynecological sarcoma in Germany (REGSA–NOGGO RU1).
36. Mehrstufiges Behadlungskonzept bei Plazenta percreta: RALH (roboterassistierte laparoskopische Hysterektomie) nach LISA (leaving die Plazenta in-situ Approach) und interventionell radiologischer Embolisation
37. Prospective identification of prognostic factors for patients with early failure of advanced ovarian cancer who undergo primary cytoreductive surgery followed by chemotherapy: The AGO-OVAR 19/FRAGILE study (NCT02828618).
38. Quality of life in patients with advanced high-grade ovarian cancer (HGOC) receiving maintenance therapies after first-line (1L) chemotherapy in the randomized phase III PAOLA-1/ENGOT-ov25 trial (NCT02477644).
39. Diphenhydramine increases the therapeutic window for platinum drugs by simultaneously sensitizing tumor cells and protecting normal cells
40. CAF-Associated Paracrine Signaling Worsens Outcome and Potentially Contributes to Chemoresistance in Epithelial Ovarian Cancer
41. [18F]FDG PET/MRI vs. PET/CT for whole-body staging in patients with recurrent malignancies of the female pelvis: initial results
42. Intraoperative Navigation in Robotically Assisted Compartmental Surgery of Uterine Cancer by Visualisation of Embryologically Derived Lymphatic Networks With Indocyanine-Green (ICG)
43. Total mesometrial resection (TMMR) for cervical cancer FIGO IB–IIA: first results from the multicentric TMMR register study
44. Prognostic Significance of SLFN11 Methylation in Plasma Cell-Free DNA in Advanced High-Grade Serous Ovarian Cancer
45. Postural and gait performance in children with attention deficit/hyperactivity disorder
46. Association of Soluble B7-H4 and Circulating Tumor Cells in Blood of Advanced Epithelial Ovarian Cancer Patients
47. Krebsfeldchirurgie des Endometriumkarzinoms
48. Accuracy of Ultrasonography and Magnetic Resonance Imaging for Preoperative Staging of Cervical Cancer—Analysis of Patients from the Prospective Study on Total Mesometrial Resection
49. Megalographia in Children with Cerebellar Lesions and in Children with Attention-Deficit/Hyperactivity Disorder
50. Timing of conditioned eyeblink responses is impaired in children with attention-deficit/hyperactivity disorder
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.